Back to Results
First PageMeta Content
Pharmacology / Research / Design of experiments / Evaluation methods / Bioethics / Attention deficit hyperactivity disorder / Clinical trial / Placebo-controlled study / Placebo / Medicine / Science / Clinical research


N22-331S014 Clonidine Statistical
Add to Reading List

Open Document

File Size: 2,00 MB

Share Result on Facebook

City

Reference / /

Company

Shionogi Inc. / Age Subgroup / SPECIAL/SUBGROUP / Race Subgroup / OTHER SPECIAL/SUBGROUP / Gender Subgroup / /

Event

Product Recall / Product Issues / FDA Phase / /

IndustryTerm

investigative site / treatment of attention deficit hyperactivity disorder / Web Response System / /

MedicalCondition

ADHD / disease / attention deficit hyperactivity disorder / Illness Scale / Affective Disorders / Mental Disorders / blindness / /

MedicalTreatment

adjunctive therapy / /

Organization

U.S. Department of Health and Human Services / Standard Biometrics Division / Translational Sciences Office / Division of Psychiatry Products Clinical Team / FDA / Food and Drug Administration Center for Drug Evaluation / Research Office / Division Director Medical Division / /

Person

Concurring Reviewers / Kooros Mahjoob / Jing Zhang / Roberta Glass / Yang Wang / /

Position

investigator / Team Leader / EXECUTIVE / Clinical Team Leader Project Manager / /

Product

Extended Release Tablets / clonidine hydrochloride / Study / period / This / Extended / KAP-401 / This supplement / /

Technology

adam / CGI / /

URL

http /

SocialTag